Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Sarcoma × Ado-Trastuzumab Emtansine × Clear all

Sponsor

Conditions

Breast Neoplasms 35 Stomach Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Sarcoma, Synovial 1 Rhabdomyosarcoma 1 Pleuropulmonary blastoma 1 Patient Preference 1 Pancreatic Neoplasms 1 Neurofibrosarcoma 1 Neuroblastoma 1 Multiple Myeloma 1 Lymphoma 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 HER2-positive Breast Cancer 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Doxorubicin 31 Ifosfamide 22 pazopanib 17 Gemcitabine 15 Cyclophosphamide 14 Radiotherapy 13 pembrolizumab 11 Filgrastim 10 Docetaxel 10 Vincristine 9 Sirolimus 9 Etoposide 9 Irinotecan 8 Bevacizumab 8 Sorafenib 7 temsirolimus 6 olaratumab 6 eribulin 6 Mesna 6 cixutumumab 5 Trabectedin 5 Radiosurgery 5 Radiation 5 Magnetic Resonance Spectroscopy 5 Granulocyte Colony-Stimulating Factor 5 tazemetostat 4 etoposide phosphate 4 Temozolomide 4 Nivolumab 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡